Funding
The Medical Research Council (MRC) is the principal source of research funding. A total budget of £25m p.a. is set every five years following an
Institute-wide review of resources. This review takes place after the quinquennial peer review (conducted by MRC Research Boards) of the programmes of the individual Divisions.
The Institute also attracts funding support from a wide range of different agencies, including medical research charities, international sources, particularly the EU, and from industrial and commercial companies:
- Arthritis Research UK
- Association for International Cancer Research (AICR)
- Asthma UK
- Biotechnology and Biological Sciences Research Council (BBSRC)
- British Council
- British Heart Foundation
- British Neurological Research Trust
- Burroughs Wellcome fund
- Cancer Research UK
- Diabetes UK
- European Commission
- European Molecular Biology Organization (EMBO)
- European Research Council (ERC)
- GlaxoSmithKline UK
- Health Protection Agency
- Heiser Program for Research in Leprosy and Tuberculosis
- Howard Hughes Medical Institute
- Human Frontier Science Program (HFSP)
- Imperial College
- International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
- International Spinal Research Trust
- Lady Tata Memorial Trust
- Leukaemia & Lymphoma Research
- Leukaemia Society of America
- Leverhulme Trust
- Medical Research Council Technology
- National Institute of Health (US)
- National Kidney Research Fund
- Nuffield Foundation
- Parkinson's Disease Society
- Roche
- The Royal Society
- University College London
- Wellcome Trust
- World Health Organisation (WHO)
Top of page